Quick Answer
Passage BIO, Inc. reported Shares Outstanding of 3.18 million shares for fiscal year 2025.
Passage BIO, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 3.18M | +0.7% |
| 2024 | 3.16M | -94.2% |
| 2023 | 54.94M | +0.6% |
| 2022 | 54.61M | +0.7% |
| 2021 | 54.24M | +18.9% |
| 2020 | 45.61M | +962.5% |
| 2019 | 4.29M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 3.18M | -94.9% | +0.0% |
| June 30, 2025 | 3.18M | -94.9% | -94.9% |
| March 31, 2025 | 62.15M | +0.9% | +1865.8% |
| December 31, 2024 | 3.16M | -94.2% | -94.9% |
| September 30, 2024 | 61.77M | +12.7% | +0.0% |
| June 30, 2024 | 61.75M | +12.8% | +0.2% |
| March 31, 2024 | 61.61M | +12.8% | +12.1% |
| December 31, 2023 | 54.94M | +0.6% | +0.2% |
- Passage BIO, Inc. showed an increase of +0.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Passage BIO, Inc.’s shares outstanding has declined by 25.9% (from 4.29 million shares to 3.18 million shares).
- The most recent figure is from Passage BIO, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: